Global COVID-19 Inactivated Vaccine Market Size, Status and Forecast 2022

SKU ID : QYR-19772640 | Publishing Date : 23-Dec-2021 | No. of pages : 128

Detailed TOC of Global COVID-19 Inactivated Vaccine Market Size, Status and Forecast 2022

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global COVID-19 Inactivated Vaccine Market Size Growth Rate by Type (2021-2027)
        1.2.2 In Clinical Trials
        1.2.3 Out-of-Clinical Trials
    1.3 Market by Application
        1.3.1 Global COVID-19 Inactivated Vaccine Market Share by Application (2021-2027)
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered

2 Executive Summary
    2.1 Global COVID-19 Inactivated Vaccine Market Size
     2.2 COVID-19 Inactivated Vaccine Market Size by Regions
        2.2.1 COVID-19 Inactivated Vaccine Growth Rate by Regions (2021-2027)
        2.2.2 COVID-19 Inactivated Vaccine Market Share by Regions (2021-2027)
    2.3 Industry Trends
        2.3.1 Market Top Trends
        2.3.2 Market Use Cases

3 Key Players
    3.1 COVID-19 Inactivated Vaccine Revenue by Players (2020-2021)
    3.2 COVID-19 Inactivated Vaccine Key Players Headquaters and Area Served
    3.3 Key Players COVID-19 Inactivated Vaccine Product/Solution/Service
    3.4 Date of Enter into COVID-19 Inactivated Vaccine Market
    3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown by Type and by Application
    4.1 Global COVID-19 Inactivated Vaccine Market Size by Type (2021-2027)
    4.2 Global COVID-19 Inactivated Vaccine Market Size by Application (2021-2027)

5 North America
   5.1 North America COVID-19 Inactivated Vaccine Market Forecast (2021-2027)
    5.2 COVID-19 Inactivated Vaccine Key Players in North America
    5.3 North America COVID-19 Inactivated Vaccine Market Size by Type
    5.4 North America COVID-19 Inactivated Vaccine Market Size by Application
        6.4.4 Canada

6 Europe
    6.1 Europe COVID-19 Inactivated Vaccine Market Forecast (2021-2027)
    6.2 COVID-19 Inactivated Vaccine Key Players in Europe
    6.3 Europe COVID-19 Inactivated Vaccine Market Size by Type
    6.4 Europe COVID-19 Inactivated Vaccine Market Size by Application

7 Japan
    7.1 Japan COVID-19 Inactivated Vaccine Market Forecast (2021-2027)
    7.2 COVID-19 Inactivated Vaccine Key Players in Europe
    7.3 Japan COVID-19 Inactivated Vaccine Market Size by Type
    7.4 Japan COVID-19 Inactivated Vaccine Market Size by Application

8 Rest of World
    8.1 China
        8.1.1 China COVID-19 Inactivated Vaccine Market Analysis
        8.1.2 Key Players in China
    8.2 Southeast Asia
        8.2.1 Southeast Asia COVID-19 Inactivated Vaccine Market Analysis
        8.2.2 Key Players in Southeast Asia
    8.3 India
        8.3.1 India COVID-19 Inactivated Vaccine Market Analysis
        8.3.2 Key Players in India

9 International Player Profiles
    9.1 Inovio Pharmaceuticals
        9.1.1 Inovio Pharmaceuticals Company Details
        9.1.2 Inovio Pharmaceuticals Description and Business Overview
        9.1.3 Inovio Pharmaceuticals COVID-19 Inactivated Vaccine Introduction
        9.1.4 Inovio Pharmaceuticals Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
        9.1.5 Inovio Pharmaceuticals Recent Development
    9.2 Takis Biotech (Evvivax)
        9.2.1 Takis Biotech (Evvivax) Company Details
        9.2.2 Takis Biotech (Evvivax) Description and Business Overview
        9.2.3 Takis Biotech (Evvivax) COVID-19 Inactivated Vaccine Introduction
        9.2.4 Takis Biotech (Evvivax) Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
        9.2.5 Takis Biotech (Evvivax) Recent Development
    9.3 Zydus Cadila
        9.3.1 Zydus Cadila Company Details
        9.3.2 Zydus Cadila Description and Business Overview
        9.3.3 Zydus Cadila COVID-19 Inactivated Vaccine Introduction
        9.3.4 Zydus Cadila Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
        9.3.5 Zydus Cadila Recent Development
    9.4 Codagenix, Inc.
        9.4.1 Codagenix, Inc. Company Details
        9.4.2 Codagenix, Inc. Description and Business Overview
        9.4.3 Codagenix, Inc. COVID-19 Inactivated Vaccine Introduction
        9.4.4 Codagenix, Inc. Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
        9.4.5 Codagenix, Inc. Recent Development
    9.5 GeoVax, Inc.
        9.5.1 GeoVax, Inc. Company Details
        9.5.2 GeoVax, Inc. Description and Business Overview
        9.5.3 GeoVax, Inc. COVID-19 Inactivated Vaccine Introduction
        9.5.4 GeoVax, Inc. Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
        9.5.5 GeoVax, Inc. Recent Development
    9.6 Bravovax
        9.6.1 Bravovax Company Details
        9.6.2 Bravovax Description and Business Overview
        9.6.3 Bravovax COVID-19 Inactivated Vaccine Introduction
        9.6.4 Bravovax Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
        9.6.5 Bravovax Recent Development
    9.7 Janssen Pharmaceutical Companies
        9.7.1 Janssen Pharmaceutical Companies Company Details
        9.7.2 Janssen Pharmaceutical Companies Description and Business Overview
        9.7.3 Janssen Pharmaceutical Companies COVID-19 Inactivated Vaccine Introduction
        9.7.4 Janssen Pharmaceutical Companies Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
        9.7.5 Janssen Pharmaceutical Companies Recent Development
    9.8 Altimmune
        9.8.1 Altimmune Company Details
        9.8.2 Altimmune Description and Business Overview
        9.8.3 Altimmune COVID-19 Inactivated Vaccine Introduction
        9.8.4 Altimmune Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
        9.8.5 Altimmune Recent Development
    9.9 Vaxart
        9.9.1 Vaxart Company Details
        9.9.2 Vaxart Description and Business Overview
        9.9.3 Vaxart COVID-19 Inactivated Vaccine Introduction
        9.9.4 Vaxart Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
        9.9.5 Vaxart Recent Development
    9.10 CanSino Biologics
        9.10.1 CanSino Biologics Company Details
        9.10.2 CanSino Biologics Description and Business Overview
        9.10.3 CanSino Biologics COVID-19 Inactivated Vaccine Introduction
        9.10.4 CanSino Biologics Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
        9.10.5 CanSino Biologics Recent Development
    9.11 ExpreS2ion Biotechnologies ApS
        9.11.1 ExpreS2ion Biotechnologies ApS Company Details
        9.11.2 ExpreS2ion Biotechnologies ApS Description and Business Overview
        9.11.3 ExpreS2ion Biotechnologies ApS COVID-19 Inactivated Vaccine Introduction
        9.11.4 ExpreS2ion Biotechnologies ApS Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
        9.11.5 ExpreS2ion Biotechnologies ApS Recent Development
    9.12 Clover Biopharmaceuticals
        9.12.1 Clover Biopharmaceuticals Company Details
        9.12.2 Clover Biopharmaceuticals Description and Business Overview
        9.12.3 Clover Biopharmaceuticals COVID-19 Inactivated Vaccine Introduction
        9.12.4 Clover Biopharmaceuticals Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
        9.12.5 Clover Biopharmaceuticals Recent Development
    9.13 GSK
        9.13.1 GSK Company Details
        9.13.2 GSK Description and Business Overview
        9.13.3 GSK COVID-19 Inactivated Vaccine Introduction
        9.13.4 GSK Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
        9.13.5 GSK Recent Development
    9.14 Vaxil Bio Ltd.
        9.14.1 Vaxil Bio Ltd. Company Details
        9.14.2 Vaxil Bio Ltd. Description and Business Overview
        9.14.3 Vaxil Bio Ltd. COVID-19 Inactivated Vaccine Introduction
        9.14.4 Vaxil Bio Ltd. Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
        9.14.5 Vaxil Bio Ltd. Recent Development
    9.15 Generex
        9.15.1 Generex Company Details
        9.15.2 Generex Description and Business Overview
        9.15.3 Generex COVID-19 Inactivated Vaccine Introduction
        9.15.4 Generex Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
        9.15.5 Generex Recent Development
    9.16 Novavax, Inc.
        9.16.1  Company Details
        9.16.2 Novavax, Inc. Description and Business Overview
        9.16.3 Novavax, Inc. COVID-19 Inactivated Vaccine Introduction
        9.16.4 Novavax, Inc. Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
        9.16.5 Novavax, Inc. Recent Development
    9.17 Sanofi Pasteur
        9.17.1 Sanofi Pasteur Company Details
        9.17.2 Sanofi Pasteur Description and Business Overview
        9.17.3 Sanofi Pasteur COVID-19 Inactivated Vaccine Introduction
        9.17.4 Sanofi Pasteur Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
        9.17.5 Sanofi Pasteur Recent Development
    9.18 Baylor
        9.18.1 Baylor Company Details
        9.18.2 Baylor Description and Business Overview
        9.18.3 Baylor COVID-19 Inactivated Vaccine Introduction
        9.18.4 Baylor Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
        9.18.5 Baylor Recent Development
    9.19 iBio, Inc.
        9.19.1 iBio, Inc. Company Details
        9.19.2 iBio, Inc. Description and Business Overview
        9.19.3 iBio, Inc. COVID-19 Inactivated Vaccine Introduction
        9.19.4 iBio, Inc. Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
        9.19.5 iBio, Inc. Recent Development
    9.20 Moderna, Inc.
        9.20.1 Moderna, Inc. Company Details
        9.20.2 Moderna, Inc. Description and Business Overview
        9.20.3 Moderna, Inc. COVID-19 Inactivated Vaccine Introduction
        9.20.4 Moderna, Inc. Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
        9.20.5 Moderna, Inc. Recent Development
    9.21 Curevac
        9.21.1 Curevac Company Details
        9.21.2 Curevac Description and Business Overview
        9.21.3 Curevac COVID-19 Inactivated Vaccine Introduction
        9.21.4 Curevac Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
        9.21.5 Curevac Recent Development
    9.22 ImmunoPrecise
        9.22.1 ImmunoPrecise Company Details
        9.22.2 ImmunoPrecise Description and Business Overview
        9.22.3 ImmunoPrecise COVID-19 Inactivated Vaccine Introduction
        9.22.4 ImmunoPrecise Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
        9.22.5 ImmunoPrecise Recent Development

10 Market Dynamics
    10.1 Industry Trends
    10.2 Market Drives
    10.3 Market Challenges
    10.4 Market Restraints

11 Key Findings in This Report
12 Appendix
    12.1 Research Methodology
        12.1.1 Methodology/Research Approach
        12.1.2 Data Source
    12.2 Disclaimer
    12.3 Author Details

List of Figures, Tables and Charts Available in Global COVID-19 Inactivated Vaccine Market Size, Status and Forecast 2022

List of Tables
    Table 1. Global COVID-19 Inactivated Vaccine Market Size Growth Rate by Type (2021-2027) (US$ Million)
    Table 2. Key Players of In Clinical Trials
    Table 3. Key Players of Out-of-Clinical Trials
    Table 4. Global COVID-19 Inactivated Vaccine Market Size Growth by Application (2021-2027) (US$ Million)
    Table 5. Global COVID-19 Inactivated Vaccine Market Size by Regions (2021-2027) (US$ Million)
    Table 6. Global COVID-19 Inactivated Vaccine Market Share by Regions (2021-2027)
    Table 7. Market Top Trends
    Table 8. Market Use Cases
    Table 9. Global COVID-19 Inactivated Vaccine Revenue by Players (2020-2021) (US$ Million)
    Table 10. Global COVID-19 Inactivated Vaccine Market Share by Players (2020-2021)
    Table 11. Key Players Headquarters and Area Served
    Table 12. Key Players COVID-19 Inactivated Vaccine Product Solution and Service
    Table 13. Date of Enter into COVID-19 Inactivated Vaccine Market
    Table 14. Mergers & Acquisitions, Expansion Plans
    Table 15. Global COVID-19 Inactivated Vaccine Market Size by Type (2021-2027) (US$ Million)
    Table 16. Global COVID-19 Inactivated Vaccine Market Size Share by Type (2021-2027)
    Table 17. Global COVID-19 Inactivated Vaccine Market Size by Application (2021-2027) (US$ Million)
    Table 18. Global COVID-19 Inactivated Vaccine Market Size Share by Application (2021-2027)
    Table 19. North America Key Players COVID-19 Inactivated Vaccine Revenue (2020-2021) (US$ Million)
    Table 20. North America Key Players COVID-19 Inactivated Vaccine Market Share (2020-2021)
    Table 21. North America COVID-19 Inactivated Vaccine Market Size by Type (2021-2027) (US$ Million)
    Table 22. North America COVID-19 Inactivated Vaccine Market Share by Type (2021-2027)
    Table 23. North America COVID-19 Inactivated Vaccine Market Size by Application (2021-2027) (US$ Million)
    Table 24. North America COVID-19 Inactivated Vaccine Market Share by Application (2021-2027)
    Table 25. Europe Key Players COVID-19 Inactivated Vaccine Revenue (2020-2021) (US$ Million)
    Table 26. Europe Key Players COVID-19 Inactivated Vaccine Market Share (2020-2021)
    Table 27. Europe COVID-19 Inactivated Vaccine Market Size by Type (2021-2027) (US$ Million)
    Table 28. Europe COVID-19 Inactivated Vaccine Market Share by Type (2021-2027)
    Table 29. Europe COVID-19 Inactivated Vaccine Market Size by Application (2021-2027) (US$ Million)
    Table 30. Europe COVID-19 Inactivated Vaccine Market Share by Application (2021-2027)
    Table 31. Japan Key Players COVID-19 Inactivated Vaccine Revenue (2020-2021) (US$ Million)
    Table 32. Japan Key Players COVID-19 Inactivated Vaccine Market Share (2020-2021)
    Table 33. Japan COVID-19 Inactivated Vaccine Market Size by Type (2021-2027) (US$ Million)
    Table 34. Japan COVID-19 Inactivated Vaccine Market Share by Type (2021-2027)
    Table 35. Japan COVID-19 Inactivated Vaccine Market Size by Application (2021-2027) (US$ Million)
    Table 36. Japan COVID-19 Inactivated Vaccine Market Share by Application (2021-2027)
    Table 37. Key Players in China
    Table 38. Key Players in Southeast Asia
    Table 39. Key Players in India
    Table 40. Inovio Pharmaceuticals Company Details
    Table 41. Inovio Pharmaceuticals Description and Business Overview
    Table 42. Inovio Pharmaceuticals COVID-19 Inactivated Vaccine Product
    Table 43. Inovio Pharmaceuticals Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
    Table 44. Inovio Pharmaceuticals Recent Development
    Table 45. Takis Biotech (Evvivax) Company Details
    Table 46. Takis Biotech (Evvivax) Description and Business Overview
    Table 47. Takis Biotech (Evvivax) COVID-19 Inactivated Vaccine Product
    Table 48. Takis Biotech (Evvivax) Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
    Table 49. Takis Biotech (Evvivax) Recent Development
    Table 50. Zydus Cadila Company Details
    Table 51. Zydus Cadila Description and Business Overview
    Table 52. Zydus Cadila COVID-19 Inactivated Vaccine Product
    Table 53. Zydus Cadila Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
    Table 54. Zydus Cadila Recent Development
    Table 55. Codagenix, Inc. Company Details
    Table 56. Codagenix, Inc. Description and Business Overview
    Table 57. Codagenix, Inc. COVID-19 Inactivated Vaccine Product
    Table 58. Codagenix, Inc. Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
    Table 59. Codagenix, Inc. Recent Development
    Table 60. GeoVax, Inc. Company Details
    Table 61. GeoVax, Inc. Description and Business Overview
    Table 62. GeoVax, Inc. COVID-19 Inactivated Vaccine Product
    Table 63. GeoVax, Inc. Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
    Table 64. GeoVax, Inc. Recent Development
    Table 65. Bravovax Company Details
    Table 66. Bravovax Description and Business Overview
    Table 67. Bravovax COVID-19 Inactivated Vaccine Product
    Table 68. Bravovax Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
    Table 69. Bravovax Recent Development
    Table 70. Janssen Pharmaceutical Companies Company Details
    Table 71. Janssen Pharmaceutical Companies Description and Business Overview
    Table 72. Janssen Pharmaceutical Companies COVID-19 Inactivated Vaccine Product
    Table 73. Janssen Pharmaceutical Companies Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
    Table 74. Janssen Pharmaceutical Companies Recent Development
    Table 75. Altimmune Company Details
    Table 76. Altimmune Description and Business Overview
    Table 77. Altimmune COVID-19 Inactivated Vaccine Product
    Table 78. Altimmune Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
    Table 79. Altimmune Recent Development
    Table 80. Vaxart Company Details
    Table 81. Vaxart Description and Business Overview
    Table 82. Vaxart COVID-19 Inactivated Vaccine Product
    Table 83. Vaxart Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
    Table 84. Vaxart Recent Development
    Table 85. CanSino Biologics Company Details
    Table 86. CanSino Biologics Description and Business Overview
    Table 87. CanSino Biologics COVID-19 Inactivated Vaccine Product
    Table 88. CanSino Biologics Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
    Table 89. CanSino Biologics Recent Development
    Table 90. ExpreS2ion Biotechnologies ApS Company Details
    Table 91. ExpreS2ion Biotechnologies ApS Description and Business Overview
    Table 92. ExpreS2ion Biotechnologies ApS COVID-19 Inactivated Vaccine Product
    Table 93. ExpreS2ion Biotechnologies ApS Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
    Table 94. ExpreS2ion Biotechnologies ApS Recent Development
    Table 95. Clover Biopharmaceuticals Company Details
    Table 96. Clover Biopharmaceuticals Description and Business Overview
    Table 97. Clover Biopharmaceuticals COVID-19 Inactivated Vaccine Product
    Table 98. Clover Biopharmaceuticals Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
    Table 99. Clover Biopharmaceuticals Recent Development
    Table 100. GSK Company Details
    Table 101. GSK Description and Business Overview
    Table 102. GSK COVID-19 Inactivated Vaccine Product
    Table 103. GSK Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
    Table 104. GSK Recent Development
    Table 105. Vaxil Bio Ltd. Company Details
    Table 106. Vaxil Bio Ltd. Description and Business Overview
    Table 107. Vaxil Bio Ltd. COVID-19 Inactivated Vaccine Product
    Table 108. Vaxil Bio Ltd. Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
    Table 109. Vaxil Bio Ltd. Recent Development
    Table 110. Generex Company Details
    Table 111. Generex Description and Business Overview
    Table 112. Generex COVID-19 Inactivated Vaccine Product
    Table 113. Generex Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
    Table 114. Generex Recent Development
    Table 115. Novavax, Inc. Company Details
    Table 116. Novavax, Inc. Description and Business Overview
    Table 117. Novavax, Inc. COVID-19 Inactivated Vaccine Product
    Table 118. Novavax, Inc. Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
    Table 119. Novavax, Inc. Recent Development
    Table 120. Sanofi Pasteur Company Details
    Table 121. Sanofi Pasteur Description and Business Overview
    Table 122. Sanofi Pasteur COVID-19 Inactivated Vaccine Product
    Table 123. Sanofi Pasteur Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
    Table 124. Sanofi Pasteur Recent Development
    Table 125. Baylor Company Details
    Table 126. Baylor Description and Business Overview
    Table 127. Baylor COVID-19 Inactivated Vaccine Product
    Table 128. Baylor Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
    Table 129. Baylor Recent Development
    Table 130. iBio, Inc. Company Details
    Table 131. iBio, Inc. Description and Business Overview
    Table 132. iBio, Inc. COVID-19 Inactivated Vaccine Product
    Table 133. iBio, Inc. Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
    Table 134. iBio, Inc. Recent Development
    Table 135. Moderna, Inc. Company Details
    Table 136. Moderna, Inc. Description and Business Overview
    Table 137. Moderna, Inc. COVID-19 Inactivated Vaccine Product
    Table 138. Moderna, Inc. Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
    Table 139. Moderna, Inc. Recent Development
    Table 140. Curevac Company Details
    Table 141. Curevac Description and Business Overview
    Table 142. Curevac COVID-19 Inactivated Vaccine Product
    Table 143. Curevac Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
    Table 144. Curevac Recent Development
    Table 145. ImmunoPrecise Company Details
    Table 146. ImmunoPrecise Description and Business Overview
    Table 147. ImmunoPrecise COVID-19 Inactivated Vaccine Product
    Table 148. ImmunoPrecise Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
    Table 149. ImmunoPrecise Recent Development
    Table 150. COVID-19 Inactivated Vaccine Market Trends
    Table 151. COVID-19 Inactivated Vaccine Market Drivers
    Table 152. COVID-19 Inactivated Vaccine Market Challenges
    Table 153. COVID-19 Inactivated Vaccine Market Restraints
    Table 154. Research Programs/Design for This Report
    Table 155. Key Data Information from Secondary Sources
    Table 156. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global COVID-19 Inactivated Vaccine Market Share by Type in 2021 & 2027
    Figure 2. In Clinical Trials Features
    Figure 3. Out-of-Clinical Trials Features
    Figure 4. Global COVID-19 Inactivated Vaccine Market Share by Application in 2021 & 2027
    Figure 5. Hospital Case Studies
    Figure 6. Clinic Case Studies
    Figure 7. Other Case Studies
    Figure 8. COVID-19 Inactivated Vaccine Report Years Considered
    Figure 9. Global COVID-19 Inactivated Vaccine Market Size and Growth Rate (2020-2027) (US$ Million)
    Figure 10. Global COVID-19 Inactivated Vaccine Market Share by Regions (2020-2027)
    Figure 11. Global COVID-19 Inactivated Vaccine Market Share by Players in 2021
    Figure 12. Global COVID-19 Inactivated Vaccine Market Size Market Share by Type (2021-2027)
    Figure 13. Global COVID-19 Inactivated Vaccine Market Size Market Share by Application (2021-2027)
    Figure 14. Global COVID-19 Inactivated Vaccine Revenue Market Share by Application in 2021
    Figure 15. North America COVID-19 Inactivated Vaccine Market Size 2021-2027 (US$ Million)
    Figure 16. Europe COVID-19 Inactivated Vaccine Market Size 2021-2027 (US$ Million)
    Figure 17. Japan COVID-19 Inactivated Vaccine Market Size 2021-2027 (US$ Million)
    Figure 18. COVID-19 Inactivated Vaccine Market Size in China (2021-2027) (US$ Million)
    Figure 19. COVID-19 Inactivated Vaccine Market Size in Southeast Asia (2021-2027) (US$ Million)
    Figure 20. COVID-19 Inactivated Vaccine Market Size in India (2021-2027) (US$ Million)
    Figure 21. Bottom-up and Top-down Approaches for This Report
    Figure 22. Data Triangulation
    Figure 23. Key Executives Interviewed

Keyplayers in Global COVID-19 Inactivated Vaccine Market Size, Status and Forecast 2022

Inovio Pharmaceuticals
Takis Biotech (Evvivax)
Zydus Cadila
Codagenix, Inc.
GeoVax, Inc.
Bravovax
Janssen Pharmaceutical Companies
Altimmune
Vaxart
CanSino Biologics
ExpreS2ion Biotechnologies ApS
Clover Biopharmaceuticals
GSK
Vaxil Bio Ltd.
Generex
Novavax, Inc.
Sanofi Pasteur
Baylor
iBio, Inc.
Moderna, Inc.
Curevac
ImmunoPrecise